SHE:002873 Revenue

Guiyang Xintian Pharmaceutical had revenue of 200.35M CNY in the quarter ending September 30, 2025, a decrease of -8.58%. This brings the company's revenue in the last twelve months to 755.34M, down -9.99% year-over-year. In the year 2024, Guiyang Xintian Pharmaceutical had annual revenue of 857.55M, down -10.11%.

Revenue (ttm)

755.34M

Revenue Growth

-9.99%

P/S Ratio

3.27

Revenue / Employee

449.07K

Employees

1,682

Market Cap

2.47B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	857.55M	-96.43M	-10.11%
Dec 31, 2023	953.98M	-133.69M	-12.29%
Jan 1, 2023	1.09B	117.83M	12.15%
Jan 1, 2022	969.84M	218.90M	29.15%
Dec 31, 2020	750.95M	-22.39M	-2.90%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Shanghai Universal Biotech	1.07B
Shandong Sito Bio-technology	954.76M
Zhejiang East Asia Pharmaceutical	831.56M
Jilin Jian Yisheng Pharmaceutical	639.10M
Hubei Goto Biopharm	626.28M
Jiangsu Sihuan Bioengineering	341.90M
Sailong Pharmaceutical Group	244.84M
Shanghai Serum Bio-Technology	196.76M

Revenue Rankings